nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP3A4—Pimecrolimus—atopic dermatitis	0.0835	0.124	CbGbCtD
Rimonabant—CYP1A2—Diphenhydramine—atopic dermatitis	0.0693	0.103	CbGbCtD
Rimonabant—CYP2C9—Loratadine—atopic dermatitis	0.0625	0.0928	CbGbCtD
Rimonabant—CYP2C9—Diphenhydramine—atopic dermatitis	0.0625	0.0928	CbGbCtD
Rimonabant—CYP2D6—Loratadine—atopic dermatitis	0.0571	0.0848	CbGbCtD
Rimonabant—CYP2D6—Diphenhydramine—atopic dermatitis	0.0571	0.0848	CbGbCtD
Rimonabant—CYP3A4—Tacrolimus—atopic dermatitis	0.0496	0.0737	CbGbCtD
Rimonabant—CYP3A4—Loratadine—atopic dermatitis	0.0363	0.0539	CbGbCtD
Rimonabant—CYP3A4—Methylprednisolone—atopic dermatitis	0.0332	0.0493	CbGbCtD
Rimonabant—CYP3A4—Triamcinolone—atopic dermatitis	0.0252	0.0374	CbGbCtD
Rimonabant—CYP2C9—Dexamethasone—atopic dermatitis	0.0216	0.0321	CbGbCtD
Rimonabant—CYP3A4—Betamethasone—atopic dermatitis	0.0216	0.0321	CbGbCtD
Rimonabant—CYP3A4—Prednisolone—atopic dermatitis	0.0213	0.0316	CbGbCtD
Rimonabant—CYP3A4—Hydrocortisone—atopic dermatitis	0.0202	0.03	CbGbCtD
Rimonabant—CYP3A4—Prednisone—atopic dermatitis	0.0201	0.0299	CbGbCtD
Rimonabant—CYP2D6—Dexamethasone—atopic dermatitis	0.0198	0.0293	CbGbCtD
Rimonabant—CYP3A4—Dexamethasone—atopic dermatitis	0.0126	0.0187	CbGbCtD
Rimonabant—CNR2—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00171	0.0234	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00152	0.0208	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—CXCR3—atopic dermatitis	0.00148	0.0202	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00136	0.0186	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00134	0.0183	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00122	0.0167	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.0012	0.0164	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL22—atopic dermatitis	0.00116	0.0159	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00107	0.0146	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL27—atopic dermatitis	0.00103	0.0142	CbGpPWpGaD
Rimonabant—CNR1—N-cadherin signaling events—MAPK8—atopic dermatitis	0.00103	0.0141	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00101	0.0138	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000982	0.0134	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000956	0.0131	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000934	0.0128	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL17—atopic dermatitis	0.000928	0.0127	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Other—CCR5—atopic dermatitis	0.000925	0.0127	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CCL22—atopic dermatitis	0.000911	0.0125	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00088	0.012	CbGpPWpGaD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000817	0.0112	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000812	0.0111	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.0008	0.011	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00079	0.0108	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000771	0.0105	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CCL11—atopic dermatitis	0.000748	0.0102	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—BDNF—atopic dermatitis	0.000742	0.0101	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000733	0.01	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000728	0.00996	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000713	0.00976	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000713	0.00976	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000711	0.00973	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0007	0.00957	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000691	0.00945	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—NGF—atopic dermatitis	0.000658	0.00901	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000641	0.00877	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000628	0.00859	CbGpPWpGaD
Rimonabant—Dermatitis—Diphenhydramine—atopic dermatitis	0.000628	0.00248	CcSEcCtD
Rimonabant—Gastrointestinal pain—Loratadine—atopic dermatitis	0.000628	0.00248	CcSEcCtD
Rimonabant—Headache—Diphenhydramine—atopic dermatitis	0.000624	0.00247	CcSEcCtD
Rimonabant—Headache—Dimenhydrinate—atopic dermatitis	0.000624	0.00247	CcSEcCtD
Rimonabant—Nervousness—Tacrolimus—atopic dermatitis	0.000624	0.00246	CcSEcCtD
Rimonabant—Muscle spasms—Tacrolimus—atopic dermatitis	0.000618	0.00244	CcSEcCtD
Rimonabant—Vomiting—Pimecrolimus—atopic dermatitis	0.000613	0.00242	CcSEcCtD
Rimonabant—CNR2—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000612	0.00838	CbGpPWpGaD
Rimonabant—Psychotic disorder—Methylprednisolone—atopic dermatitis	0.000611	0.00241	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCR3—atopic dermatitis	0.00061	0.00834	CbGpPWpGaD
Rimonabant—Rash—Pimecrolimus—atopic dermatitis	0.000608	0.0024	CcSEcCtD
Rimonabant—Dermatitis—Pimecrolimus—atopic dermatitis	0.000607	0.0024	CcSEcCtD
Rimonabant—Abdominal pain—Loratadine—atopic dermatitis	0.000607	0.0024	CcSEcCtD
Rimonabant—Headache—Pimecrolimus—atopic dermatitis	0.000604	0.00238	CcSEcCtD
Rimonabant—Tremor—Tacrolimus—atopic dermatitis	0.000602	0.00238	CcSEcCtD
Rimonabant—Irritability—Methylprednisolone—atopic dermatitis	0.000597	0.00236	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000596	0.00235	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCL22—atopic dermatitis	0.000596	0.00815	CbGpPWpGaD
Rimonabant—Mood swings—Triamcinolone—atopic dermatitis	0.000594	0.00234	CcSEcCtD
Rimonabant—Mood swings—Methylprednisolone—atopic dermatitis	0.000592	0.00234	CcSEcCtD
Rimonabant—Nausea—Diphenhydramine—atopic dermatitis	0.000592	0.00234	CcSEcCtD
Rimonabant—Nausea—Dimenhydrinate—atopic dermatitis	0.000592	0.00234	CcSEcCtD
Rimonabant—Paraesthesia—Mometasone—atopic dermatitis	0.000592	0.00234	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000587	0.00803	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CCL27—atopic dermatitis	0.000584	0.008	CbGpPWpGaD
Rimonabant—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000581	0.00794	CbGpPWpGaD
Rimonabant—Lethargy—Dexamethasone—atopic dermatitis	0.00058	0.00229	CcSEcCtD
Rimonabant—Lethargy—Betamethasone—atopic dermatitis	0.00058	0.00229	CcSEcCtD
Rimonabant—Decreased appetite—Mometasone—atopic dermatitis	0.000573	0.00226	CcSEcCtD
Rimonabant—Nausea—Pimecrolimus—atopic dermatitis	0.000573	0.00226	CcSEcCtD
Rimonabant—Fatigue—Mometasone—atopic dermatitis	0.000568	0.00224	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000566	0.00774	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00056	0.00766	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00056	0.00766	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000558	0.00764	CbGpPWpGaD
Rimonabant—Convulsion—Tacrolimus—atopic dermatitis	0.000557	0.0022	CcSEcCtD
Rimonabant—Psychotic disorder—Dexamethasone—atopic dermatitis	0.000555	0.00219	CcSEcCtD
Rimonabant—Psychotic disorder—Betamethasone—atopic dermatitis	0.000555	0.00219	CcSEcCtD
Rimonabant—CNR2—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000552	0.00755	CbGpPWpGaD
Rimonabant—Asthenia—Loratadine—atopic dermatitis	0.000551	0.00217	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000549	0.00751	CbGpPWpGaD
Rimonabant—Anxiety—Tacrolimus—atopic dermatitis	0.000545	0.00215	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—NPS—atopic dermatitis	0.000543	0.00743	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—TAC1—atopic dermatitis	0.000543	0.00743	CbGpPWpGaD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000543	0.00214	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NFKBIA—atopic dermatitis	0.000543	0.00743	CbGpPWpGaD
Rimonabant—Irritability—Dexamethasone—atopic dermatitis	0.000543	0.00214	CcSEcCtD
Rimonabant—Irritability—Betamethasone—atopic dermatitis	0.000543	0.00214	CcSEcCtD
Rimonabant—Influenza—Triamcinolone—atopic dermatitis	0.000542	0.00214	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000539	0.00213	CcSEcCtD
Rimonabant—Mood swings—Dexamethasone—atopic dermatitis	0.000539	0.00213	CcSEcCtD
Rimonabant—Mood swings—Betamethasone—atopic dermatitis	0.000539	0.00213	CcSEcCtD
Rimonabant—Dry mouth—Tacrolimus—atopic dermatitis	0.000535	0.00211	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000535	0.00211	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CXCR3—atopic dermatitis	0.000533	0.00729	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CCL27—atopic dermatitis	0.000531	0.00726	CbGpPWpGaD
Rimonabant—Amnesia—Prednisone—atopic dermatitis	0.000527	0.00208	CcSEcCtD
Rimonabant—Diarrhoea—Loratadine—atopic dermatitis	0.000525	0.00207	CcSEcCtD
Rimonabant—Infection—Tacrolimus—atopic dermatitis	0.000521	0.00206	CcSEcCtD
Rimonabant—Abdominal pain—Mometasone—atopic dermatitis	0.000521	0.00206	CcSEcCtD
Rimonabant—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000514	0.00203	CcSEcCtD
Rimonabant—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000513	0.00202	CcSEcCtD
Rimonabant—Infestation—Hydrocortisone—atopic dermatitis	0.000513	0.00202	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000512	0.007	CbGpPWpGaD
Rimonabant—Skin disorder—Tacrolimus—atopic dermatitis	0.000509	0.00201	CcSEcCtD
Rimonabant—Dizziness—Loratadine—atopic dermatitis	0.000508	0.002	CcSEcCtD
Rimonabant—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000507	0.002	CcSEcCtD
Rimonabant—Lethargy—Prednisone—atopic dermatitis	0.000505	0.00199	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000503	0.00199	CcSEcCtD
Rimonabant—Anorexia—Tacrolimus—atopic dermatitis	0.0005	0.00197	CcSEcCtD
Rimonabant—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000488	0.00193	CcSEcCtD
Rimonabant—Vomiting—Loratadine—atopic dermatitis	0.000488	0.00193	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000487	0.00666	CbGpPWpGaD
Rimonabant—Rash—Loratadine—atopic dermatitis	0.000484	0.00191	CcSEcCtD
Rimonabant—Psychotic disorder—Prednisone—atopic dermatitis	0.000484	0.00191	CcSEcCtD
Rimonabant—Dermatitis—Loratadine—atopic dermatitis	0.000484	0.00191	CcSEcCtD
Rimonabant—Infestation—Methylprednisolone—atopic dermatitis	0.000482	0.0019	CcSEcCtD
Rimonabant—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000482	0.0019	CcSEcCtD
Rimonabant—Headache—Loratadine—atopic dermatitis	0.000481	0.0019	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00048	0.00657	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CCR3—atopic dermatitis	0.000478	0.00654	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CCL17—atopic dermatitis	0.000476	0.00651	CbGpPWpGaD
Rimonabant—Insomnia—Tacrolimus—atopic dermatitis	0.000474	0.00187	CcSEcCtD
Rimonabant—Asthenia—Mometasone—atopic dermatitis	0.000473	0.00187	CcSEcCtD
Rimonabant—Irritability—Prednisone—atopic dermatitis	0.000473	0.00187	CcSEcCtD
Rimonabant—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000472	0.00186	CcSEcCtD
Rimonabant—Paraesthesia—Tacrolimus—atopic dermatitis	0.000471	0.00186	CcSEcCtD
Rimonabant—Mood swings—Prednisone—atopic dermatitis	0.000469	0.00185	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL22—atopic dermatitis	0.000467	0.00639	CbGpPWpGaD
Rimonabant—Pruritus—Mometasone—atopic dermatitis	0.000466	0.00184	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000459	0.00627	CbGpPWpGaD
Rimonabant—Hallucination—Hydrocortisone—atopic dermatitis	0.000458	0.00181	CcSEcCtD
Rimonabant—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000456	0.0018	CcSEcCtD
Rimonabant—Nausea—Loratadine—atopic dermatitis	0.000456	0.0018	CcSEcCtD
Rimonabant—Decreased appetite—Tacrolimus—atopic dermatitis	0.000456	0.0018	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000453	0.00179	CcSEcCtD
Rimonabant—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000452	0.00179	CcSEcCtD
Rimonabant—Fatigue—Tacrolimus—atopic dermatitis	0.000452	0.00178	CcSEcCtD
Rimonabant—Diarrhoea—Mometasone—atopic dermatitis	0.000451	0.00178	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000444	0.00607	CbGpPWpGaD
Rimonabant—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000439	0.00173	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000439	0.006	CbGpPWpGaD
Rimonabant—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000435	0.00172	CcSEcCtD
Rimonabant—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000435	0.00172	CcSEcCtD
Rimonabant—CNR1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000433	0.00592	CbGpPWpGaD
Rimonabant—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000432	0.00171	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CXCL10—atopic dermatitis	0.000431	0.00589	CbGpPWpGaD
Rimonabant—Hallucination—Methylprednisolone—atopic dermatitis	0.00043	0.0017	CcSEcCtD
Rimonabant—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000429	0.00169	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—TAC1—atopic dermatitis	0.000426	0.00583	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—NPS—atopic dermatitis	0.000426	0.00583	CbGpPWpGaD
Rimonabant—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000425	0.00168	CcSEcCtD
Rimonabant—Vomiting—Mometasone—atopic dermatitis	0.000419	0.00165	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000418	0.00572	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCL27—atopic dermatitis	0.000416	0.0057	CbGpPWpGaD
Rimonabant—Rash—Mometasone—atopic dermatitis	0.000415	0.00164	CcSEcCtD
Rimonabant—Dermatitis—Mometasone—atopic dermatitis	0.000415	0.00164	CcSEcCtD
Rimonabant—Abdominal pain—Tacrolimus—atopic dermatitis	0.000415	0.00164	CcSEcCtD
Rimonabant—Headache—Mometasone—atopic dermatitis	0.000413	0.00163	CcSEcCtD
Rimonabant—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00041	0.00162	CcSEcCtD
Rimonabant—Mental disorder—Hydrocortisone—atopic dermatitis	0.000403	0.00159	CcSEcCtD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000402	0.0055	CbGpPWpGaD
Rimonabant—Malnutrition—Hydrocortisone—atopic dermatitis	0.000401	0.00158	CcSEcCtD
Rimonabant—Angiopathy—Methylprednisolone—atopic dermatitis	0.000392	0.00155	CcSEcCtD
Rimonabant—Hallucination—Betamethasone—atopic dermatitis	0.000391	0.00155	CcSEcCtD
Rimonabant—Hallucination—Dexamethasone—atopic dermatitis	0.000391	0.00155	CcSEcCtD
Rimonabant—Nausea—Mometasone—atopic dermatitis	0.000391	0.00154	CcSEcCtD
Rimonabant—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.00039	0.00154	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCL11—atopic dermatitis	0.000384	0.00525	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000382	0.00523	CbGpPWpGaD
Rimonabant—Depression—Prednisone—atopic dermatitis	0.000381	0.0015	CcSEcCtD
Rimonabant—Mental disorder—Methylprednisolone—atopic dermatitis	0.000379	0.0015	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—FCER2—atopic dermatitis	0.000378	0.00518	CbGpPWpGaD
Rimonabant—Malnutrition—Methylprednisolone—atopic dermatitis	0.000377	0.00149	CcSEcCtD
Rimonabant—Asthenia—Tacrolimus—atopic dermatitis	0.000376	0.00149	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL17—atopic dermatitis	0.000374	0.00511	CbGpPWpGaD
Rimonabant—Pruritus—Tacrolimus—atopic dermatitis	0.000371	0.00146	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCL5—atopic dermatitis	0.000371	0.00507	CbGpPWpGaD
Rimonabant—Diarrhoea—Tacrolimus—atopic dermatitis	0.000359	0.00142	CcSEcCtD
Rimonabant—Angiopathy—Dexamethasone—atopic dermatitis	0.000357	0.00141	CcSEcCtD
Rimonabant—Angiopathy—Betamethasone—atopic dermatitis	0.000357	0.00141	CcSEcCtD
Rimonabant—Convulsion—Prednisolone—atopic dermatitis	0.000356	0.0014	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL22—atopic dermatitis	0.000352	0.00481	CbGpPWpGaD
Rimonabant—Convulsion—Hydrocortisone—atopic dermatitis	0.000347	0.00137	CcSEcCtD
Rimonabant—Dizziness—Tacrolimus—atopic dermatitis	0.000347	0.00137	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CCR3—atopic dermatitis	0.000344	0.00471	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000344	0.00471	CbGpPWpGaD
Rimonabant—Hallucination—Prednisone—atopic dermatitis	0.000341	0.00135	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000341	0.00466	CbGpPWpGaD
Rimonabant—Anxiety—Hydrocortisone—atopic dermatitis	0.00034	0.00134	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000339	0.00134	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000338	0.00462	CbGpPWpGaD
Rimonabant—Connective tissue disorder—Prednisone—atopic dermatitis	0.000337	0.00133	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CCR5—atopic dermatitis	0.000334	0.00457	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000334	0.00456	CbGpPWpGaD
Rimonabant—Vomiting—Tacrolimus—atopic dermatitis	0.000333	0.00132	CcSEcCtD
Rimonabant—Rash—Tacrolimus—atopic dermatitis	0.000331	0.00131	CcSEcCtD
Rimonabant—Dermatitis—Tacrolimus—atopic dermatitis	0.00033	0.0013	CcSEcCtD
Rimonabant—Headache—Tacrolimus—atopic dermatitis	0.000329	0.0013	CcSEcCtD
Rimonabant—Convulsion—Triamcinolone—atopic dermatitis	0.000327	0.00129	CcSEcCtD
Rimonabant—Convulsion—Methylprednisolone—atopic dermatitis	0.000326	0.00129	CcSEcCtD
Rimonabant—Infection—Hydrocortisone—atopic dermatitis	0.000325	0.00128	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000324	0.00128	CcSEcCtD
Rimonabant—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000321	0.00127	CcSEcCtD
Rimonabant—Anxiety—Methylprednisolone—atopic dermatitis	0.000319	0.00126	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000318	0.00126	CcSEcCtD
Rimonabant—Skin disorder—Hydrocortisone—atopic dermatitis	0.000318	0.00125	CcSEcCtD
Rimonabant—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000316	0.00125	CcSEcCtD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000315	0.00431	CbGpPWpGaD
Rimonabant—Dry mouth—Triamcinolone—atopic dermatitis	0.000314	0.00124	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL27—atopic dermatitis	0.000314	0.00429	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CCR3—atopic dermatitis	0.000313	0.00428	CbGpPWpGaD
Rimonabant—Anorexia—Hydrocortisone—atopic dermatitis	0.000312	0.00123	CcSEcCtD
Rimonabant—Nausea—Tacrolimus—atopic dermatitis	0.000311	0.00123	CcSEcCtD
Rimonabant—Angiopathy—Prednisone—atopic dermatitis	0.000311	0.00123	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000307	0.0042	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—NPS—atopic dermatitis	0.000307	0.0042	CbGpPWpGaD
Rimonabant—Infection—Triamcinolone—atopic dermatitis	0.000306	0.00121	CcSEcCtD
Rimonabant—Infection—Methylprednisolone—atopic dermatitis	0.000305	0.00121	CcSEcCtD
Rimonabant—Insomnia—Prednisolone—atopic dermatitis	0.000303	0.0012	CcSEcCtD
Rimonabant—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000301	0.00119	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000301	0.00412	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000301	0.00412	CbGpPWpGaD
Rimonabant—Paraesthesia—Prednisolone—atopic dermatitis	0.000301	0.00119	CcSEcCtD
Rimonabant—Mental disorder—Prednisone—atopic dermatitis	0.0003	0.00118	CcSEcCtD
Rimonabant—Skin disorder—Methylprednisolone—atopic dermatitis	0.000299	0.00118	CcSEcCtD
Rimonabant—Malnutrition—Prednisone—atopic dermatitis	0.000298	0.00118	CcSEcCtD
Rimonabant—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000298	0.00118	CcSEcCtD
Rimonabant—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000297	0.00117	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—FCER2—atopic dermatitis	0.000297	0.00406	CbGpPWpGaD
Rimonabant—Convulsion—Dexamethasone—atopic dermatitis	0.000297	0.00117	CcSEcCtD
Rimonabant—Convulsion—Betamethasone—atopic dermatitis	0.000297	0.00117	CcSEcCtD
Rimonabant—Insomnia—Hydrocortisone—atopic dermatitis	0.000296	0.00117	CcSEcCtD
Rimonabant—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000294	0.00116	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000291	0.00398	CbGpPWpGaD
Rimonabant—Anxiety—Dexamethasone—atopic dermatitis	0.000291	0.00115	CcSEcCtD
Rimonabant—Anxiety—Betamethasone—atopic dermatitis	0.000291	0.00115	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—IL5—atopic dermatitis	0.000285	0.00391	CbGpPWpGaD
Rimonabant—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000284	0.00112	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000282	0.00111	CcSEcCtD
Rimonabant—Fatigue—Hydrocortisone—atopic dermatitis	0.000282	0.00111	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL17—atopic dermatitis	0.000281	0.00385	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—NPS—atopic dermatitis	0.000279	0.00381	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—TAC1—atopic dermatitis	0.000279	0.00381	CbGpPWpGaD
Rimonabant—Insomnia—Triamcinolone—atopic dermatitis	0.000279	0.0011	CcSEcCtD
Rimonabant—Insomnia—Methylprednisolone—atopic dermatitis	0.000278	0.0011	CcSEcCtD
Rimonabant—Infection—Dexamethasone—atopic dermatitis	0.000278	0.0011	CcSEcCtD
Rimonabant—Infection—Betamethasone—atopic dermatitis	0.000278	0.0011	CcSEcCtD
Rimonabant—Paraesthesia—Triamcinolone—atopic dermatitis	0.000277	0.00109	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CCL22—atopic dermatitis	0.000276	0.00378	CbGpPWpGaD
Rimonabant—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000276	0.00109	CcSEcCtD
Rimonabant—Nervous system disorder—Betamethasone—atopic dermatitis	0.000274	0.00108	CcSEcCtD
Rimonabant—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000274	0.00108	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CXCR3—atopic dermatitis	0.000273	0.00374	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00027	0.0037	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.00027	0.00107	CcSEcCtD
Rimonabant—Hyperhidrosis—Betamethasone—atopic dermatitis	0.00027	0.00107	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000269	0.00368	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000267	0.00106	CcSEcCtD
Rimonabant—Anorexia—Betamethasone—atopic dermatitis	0.000266	0.00105	CcSEcCtD
Rimonabant—Anorexia—Dexamethasone—atopic dermatitis	0.000266	0.00105	CcSEcCtD
Rimonabant—Fatigue—Triamcinolone—atopic dermatitis	0.000266	0.00105	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000265	0.00363	CbGpPWpGaD
Rimonabant—Fatigue—Methylprednisolone—atopic dermatitis	0.000265	0.00105	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000262	0.00359	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000262	0.00358	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL5—atopic dermatitis	0.000259	0.00355	CbGpPWpGaD
Rimonabant—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000259	0.00102	CcSEcCtD
Rimonabant—Convulsion—Prednisone—atopic dermatitis	0.000258	0.00102	CcSEcCtD
Rimonabant—Anxiety—Prednisone—atopic dermatitis	0.000253	0.000999	CcSEcCtD
Rimonabant—Insomnia—Betamethasone—atopic dermatitis	0.000253	0.000998	CcSEcCtD
Rimonabant—Insomnia—Dexamethasone—atopic dermatitis	0.000253	0.000998	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000252	0.000995	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000251	0.000992	CcSEcCtD
Rimonabant—Paraesthesia—Dexamethasone—atopic dermatitis	0.000251	0.000991	CcSEcCtD
Rimonabant—Paraesthesia—Betamethasone—atopic dermatitis	0.000251	0.000991	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—KIF3A—atopic dermatitis	0.000251	0.00343	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL27—atopic dermatitis	0.000246	0.00337	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000245	0.00336	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000243	0.00333	CbGpPWpGaD
Rimonabant—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000243	0.000959	CcSEcCtD
Rimonabant—Decreased appetite—Dexamethasone—atopic dermatitis	0.000243	0.000959	CcSEcCtD
Rimonabant—Decreased appetite—Betamethasone—atopic dermatitis	0.000243	0.000959	CcSEcCtD
Rimonabant—Infection—Prednisone—atopic dermatitis	0.000242	0.000954	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000241	0.000952	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000241	0.000952	CcSEcCtD
Rimonabant—Fatigue—Dexamethasone—atopic dermatitis	0.000241	0.000951	CcSEcCtD
Rimonabant—Fatigue—Betamethasone—atopic dermatitis	0.000241	0.000951	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000241	0.0033	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000241	0.0033	CbGpPWpGaD
Rimonabant—Nervous system disorder—Prednisone—atopic dermatitis	0.000239	0.000942	CcSEcCtD
Rimonabant—Skin disorder—Prednisone—atopic dermatitis	0.000236	0.000933	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000236	0.00323	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Prednisone—atopic dermatitis	0.000235	0.000929	CcSEcCtD
Rimonabant—Asthenia—Hydrocortisone—atopic dermatitis	0.000235	0.000926	CcSEcCtD
Rimonabant—Anorexia—Prednisone—atopic dermatitis	0.000232	0.000916	CcSEcCtD
Rimonabant—Pruritus—Hydrocortisone—atopic dermatitis	0.000231	0.000914	CcSEcCtD
Rimonabant—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000229	0.000902	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000229	0.000902	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCL11—atopic dermatitis	0.000227	0.0031	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CMA1—atopic dermatitis	0.000227	0.0031	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000224	0.00306	CbGpPWpGaD
Rimonabant—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000224	0.000883	CcSEcCtD
Rimonabant—Dizziness—Prednisolone—atopic dermatitis	0.000221	0.000874	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000221	0.00302	CbGpPWpGaD
Rimonabant—Asthenia—Triamcinolone—atopic dermatitis	0.000221	0.000872	CcSEcCtD
Rimonabant—Abdominal pain—Dexamethasone—atopic dermatitis	0.000221	0.000872	CcSEcCtD
Rimonabant—Abdominal pain—Betamethasone—atopic dermatitis	0.000221	0.000872	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CCL17—atopic dermatitis	0.000221	0.00302	CbGpPWpGaD
Rimonabant—Asthenia—Methylprednisolone—atopic dermatitis	0.000221	0.00087	CcSEcCtD
Rimonabant—Insomnia—Prednisone—atopic dermatitis	0.00022	0.000869	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—NPS—atopic dermatitis	0.000219	0.00299	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000219	0.00299	CbGpPWpGaD
Rimonabant—Paraesthesia—Prednisone—atopic dermatitis	0.000219	0.000863	CcSEcCtD
Rimonabant—Pruritus—Triamcinolone—atopic dermatitis	0.000218	0.00086	CcSEcCtD
Rimonabant—Pruritus—Methylprednisolone—atopic dermatitis	0.000217	0.000858	CcSEcCtD
Rimonabant—Dizziness—Hydrocortisone—atopic dermatitis	0.000216	0.000854	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000215	0.00294	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT6—atopic dermatitis	0.000213	0.00292	CbGpPWpGaD
Rimonabant—Decreased appetite—Prednisone—atopic dermatitis	0.000212	0.000835	CcSEcCtD
Rimonabant—Rash—Prednisolone—atopic dermatitis	0.000211	0.000834	CcSEcCtD
Rimonabant—Dermatitis—Prednisolone—atopic dermatitis	0.000211	0.000833	CcSEcCtD
Rimonabant—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00021	0.00083	CcSEcCtD
Rimonabant—Fatigue—Prednisone—atopic dermatitis	0.00021	0.000828	CcSEcCtD
Rimonabant—Headache—Prednisolone—atopic dermatitis	0.00021	0.000828	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CCL5—atopic dermatitis	0.00021	0.00287	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000208	0.00285	CbGpPWpGaD
Rimonabant—Vomiting—Hydrocortisone—atopic dermatitis	0.000208	0.000821	CcSEcCtD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000208	0.00284	CbGpPWpGaD
Rimonabant—Rash—Hydrocortisone—atopic dermatitis	0.000206	0.000814	CcSEcCtD
Rimonabant—Dermatitis—Hydrocortisone—atopic dermatitis	0.000206	0.000813	CcSEcCtD
Rimonabant—Headache—Hydrocortisone—atopic dermatitis	0.000205	0.000809	CcSEcCtD
Rimonabant—Dizziness—Triamcinolone—atopic dermatitis	0.000204	0.000804	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—IL5—atopic dermatitis	0.000203	0.00278	CbGpPWpGaD
Rimonabant—Dizziness—Methylprednisolone—atopic dermatitis	0.000203	0.000802	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—CXCL8—atopic dermatitis	0.000202	0.00276	CbGpPWpGaD
Rimonabant—Asthenia—Betamethasone—atopic dermatitis	0.000201	0.000792	CcSEcCtD
Rimonabant—Asthenia—Dexamethasone—atopic dermatitis	0.000201	0.000792	CcSEcCtD
Rimonabant—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000199	0.000786	CcSEcCtD
Rimonabant—Nausea—Prednisolone—atopic dermatitis	0.000199	0.000785	CcSEcCtD
Rimonabant—Pruritus—Betamethasone—atopic dermatitis	0.000198	0.000781	CcSEcCtD
Rimonabant—Pruritus—Dexamethasone—atopic dermatitis	0.000198	0.000781	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000197	0.00269	CbGpPWpGaD
Rimonabant—Vomiting—Triamcinolone—atopic dermatitis	0.000196	0.000773	CcSEcCtD
Rimonabant—Vomiting—Methylprednisolone—atopic dermatitis	0.000195	0.000771	CcSEcCtD
Rimonabant—Nausea—Hydrocortisone—atopic dermatitis	0.000194	0.000767	CcSEcCtD
Rimonabant—Rash—Triamcinolone—atopic dermatitis	0.000194	0.000767	CcSEcCtD
Rimonabant—Dermatitis—Triamcinolone—atopic dermatitis	0.000194	0.000766	CcSEcCtD
Rimonabant—Rash—Methylprednisolone—atopic dermatitis	0.000194	0.000765	CcSEcCtD
Rimonabant—Dermatitis—Methylprednisolone—atopic dermatitis	0.000194	0.000764	CcSEcCtD
Rimonabant—Headache—Triamcinolone—atopic dermatitis	0.000193	0.000762	CcSEcCtD
Rimonabant—Headache—Methylprednisolone—atopic dermatitis	0.000193	0.00076	CcSEcCtD
Rimonabant—Abdominal pain—Prednisone—atopic dermatitis	0.000192	0.000759	CcSEcCtD
Rimonabant—Diarrhoea—Dexamethasone—atopic dermatitis	0.000191	0.000755	CcSEcCtD
Rimonabant—Diarrhoea—Betamethasone—atopic dermatitis	0.000191	0.000755	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000191	0.00261	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CCL5—atopic dermatitis	0.00019	0.0026	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000189	0.00258	CbGpPWpGaD
Rimonabant—Dizziness—Betamethasone—atopic dermatitis	0.000185	0.00073	CcSEcCtD
Rimonabant—Dizziness—Dexamethasone—atopic dermatitis	0.000185	0.00073	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CCR3—atopic dermatitis	0.000185	0.00253	CbGpPWpGaD
Rimonabant—Nausea—Triamcinolone—atopic dermatitis	0.000183	0.000722	CcSEcCtD
Rimonabant—Nausea—Methylprednisolone—atopic dermatitis	0.000183	0.000721	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CMA1—atopic dermatitis	0.000178	0.00243	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL11—atopic dermatitis	0.000178	0.00243	CbGpPWpGaD
Rimonabant—Vomiting—Betamethasone—atopic dermatitis	0.000178	0.000701	CcSEcCtD
Rimonabant—Vomiting—Dexamethasone—atopic dermatitis	0.000178	0.000701	CcSEcCtD
Rimonabant—Rash—Betamethasone—atopic dermatitis	0.000176	0.000696	CcSEcCtD
Rimonabant—Rash—Dexamethasone—atopic dermatitis	0.000176	0.000696	CcSEcCtD
Rimonabant—Dermatitis—Betamethasone—atopic dermatitis	0.000176	0.000695	CcSEcCtD
Rimonabant—Dermatitis—Dexamethasone—atopic dermatitis	0.000176	0.000695	CcSEcCtD
Rimonabant—Headache—Betamethasone—atopic dermatitis	0.000175	0.000691	CcSEcCtD
Rimonabant—Headache—Dexamethasone—atopic dermatitis	0.000175	0.000691	CcSEcCtD
Rimonabant—Asthenia—Prednisone—atopic dermatitis	0.000175	0.000689	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000173	0.00237	CbGpPWpGaD
Rimonabant—Pruritus—Prednisone—atopic dermatitis	0.000172	0.00068	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CCR5—atopic dermatitis	0.000171	0.00235	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT6—atopic dermatitis	0.000167	0.00229	CbGpPWpGaD
Rimonabant—Diarrhoea—Prednisone—atopic dermatitis	0.000167	0.000657	CcSEcCtD
Rimonabant—Nausea—Betamethasone—atopic dermatitis	0.000166	0.000655	CcSEcCtD
Rimonabant—Nausea—Dexamethasone—atopic dermatitis	0.000166	0.000655	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—TAC1—atopic dermatitis	0.000165	0.00225	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NPS—atopic dermatitis	0.000165	0.00225	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000164	0.00225	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCR3—atopic dermatitis	0.000162	0.00221	CbGpPWpGaD
Rimonabant—Dizziness—Prednisone—atopic dermatitis	0.000161	0.000635	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000158	0.00217	CbGpPWpGaD
Rimonabant—Vomiting—Prednisone—atopic dermatitis	0.000155	0.000611	CcSEcCtD
Rimonabant—Rash—Prednisone—atopic dermatitis	0.000153	0.000606	CcSEcCtD
Rimonabant—Dermatitis—Prednisone—atopic dermatitis	0.000153	0.000605	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—IL5—atopic dermatitis	0.000153	0.00209	CbGpPWpGaD
Rimonabant—Headache—Prednisone—atopic dermatitis	0.000152	0.000602	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000149	0.00204	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000148	0.00203	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCR3—atopic dermatitis	0.000145	0.00198	CbGpPWpGaD
Rimonabant—Nausea—Prednisone—atopic dermatitis	0.000145	0.000571	CcSEcCtD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000143	0.00196	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000134	0.00184	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL10—atopic dermatitis	0.000131	0.00179	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TAC1—atopic dermatitis	0.000129	0.00177	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NPS—atopic dermatitis	0.000129	0.00177	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000128	0.00175	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000127	0.00174	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000127	0.00173	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL5—atopic dermatitis	0.00012	0.00164	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000114	0.00156	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCL5—atopic dermatitis	0.000112	0.00154	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—IL2—atopic dermatitis	0.000109	0.00149	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NGF—atopic dermatitis	0.000104	0.00142	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000104	0.00142	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000102	0.0014	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000102	0.00139	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCR5—atopic dermatitis	0.000101	0.00139	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—atopic dermatitis	9.9e-05	0.00135	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	9.27e-05	0.00127	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	9.27e-05	0.00127	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.95e-05	0.00123	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCL5—atopic dermatitis	8.82e-05	0.00121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.7e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NFKBIA—atopic dermatitis	8.58e-05	0.00117	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—atopic dermatitis	8.56e-05	0.00117	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NGF—atopic dermatitis	8.17e-05	0.00112	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL8—atopic dermatitis	8.13e-05	0.00111	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCR5—atopic dermatitis	7.95e-05	0.00109	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—atopic dermatitis	7.77e-05	0.00106	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NFKBIA—atopic dermatitis	6.74e-05	0.000922	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL8—atopic dermatitis	6.12e-05	0.000838	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—atopic dermatitis	5.85e-05	0.0008	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—atopic dermatitis	5.82e-05	0.000796	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MAPK8—atopic dermatitis	5.38e-05	0.000737	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL8—atopic dermatitis	4.8e-05	0.000657	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—atopic dermatitis	4.59e-05	0.000628	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GLB1—atopic dermatitis	4.58e-05	0.000626	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—atopic dermatitis	4.57e-05	0.000625	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GLB1—atopic dermatitis	4.54e-05	0.000621	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADSL—atopic dermatitis	4.39e-05	0.0006	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADSL—atopic dermatitis	4.35e-05	0.000595	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MAPK8—atopic dermatitis	4.23e-05	0.000578	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GLB1—atopic dermatitis	3.88e-05	0.00053	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADSL—atopic dermatitis	3.72e-05	0.000508	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—atopic dermatitis	3.44e-05	0.00047	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.31e-05	0.000452	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.99e-05	0.000409	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.87e-05	0.000392	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.82e-05	0.000386	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—atopic dermatitis	2.7e-05	0.000369	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.48e-05	0.000203	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARA—atopic dermatitis	1.47e-05	0.000201	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARA—atopic dermatitis	1.26e-05	0.000172	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARA—atopic dermatitis	9.71e-06	0.000133	CbGpPWpGaD
